Eisai has launched ziconotide [Prialt] in the UK for the treatment of severe chronic pain

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1546, 2006-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An orodispersible formulation of donepezil [Aricept Evess; Eisai] has been launched in the UK for the treatment of Alzheimer's disease

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Ziconotide worth it for zapping chronic pain in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

An evaluation of intrathecal ziconotide for the treatment of chronic pain

By Jain K.K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2403-2410

Informa Healthcare

Access to resources Recommend Favorite

Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain

Current Medicinal Chemistry, Vol. 11, Iss. 23, 2004-12 ,pp. : 3029-3040

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab [Avastin; Roche] has been launched in the UK as a first-line treatment for metastatic breast cancer

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite